Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Seasonal Allergic Rhinitis

In brief

This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis.

Key facts

Study ID

NCT01277341

Run by

Bausch & Lomb Incorporated

People needed

601

Starts

2010-12-01

Expected to finish

2011-05-01

Last updated by the study team

2020-10-05

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female at least 12 years of age with a history of mountain cedar allergy

You may not qualify if…

• No active nasal infection or nasal abnormality that would affect subject safety or symptom assessments

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.